Search

Your search keyword '"Grivas P"' showing total 1,130 results

Search Constraints

Start Over You searched for: Author "Grivas P" Remove constraint Author: "Grivas P"
1,130 results on '"Grivas P"'

Search Results

101. Habitat use and selection patterns inform habitat conservation priorities of an endangered large carnivore in southern Europe

102. An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

104. Real-time high-bandwidth mm-wave 5G NR signal transmission with analog radio-over-fiber fronthaul over multi-core fiber

106. 8P Factors associated with primary progression in patients with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV): Analysis of the UNITE study

108. ExoClock Project. III. 450 New Exoplanet Ephemerides from Ground and Space Observations

109. Transition technologies towards 6G networks

110. Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)

116. Establishing consensus on the best practice guidelines for the use of bracing in adolescent idiopathic scoliosis

117. Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma

119. Ureteral carcinoma metastasizing to the testicle: Can misdiagnosis of orchiepididymitis be avoided?

120. Changes & CHOICES.

121. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

122. Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.

123. An intelligent platform-based tool for the development of digital transformation strategies.

124. Serial vs. Integrated Outdoor Combined Training Programs for Health Promotion in Middle-Aged Males

125. Midkine-a Regulates the Formation of a Fibrotic Scar During Zebrafish Heart Regeneration

126. First Report of Two Cases of Acute Gastric Ischemia after Robot-Assisted Radical Cystectomy

131. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

135. Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study

136. Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium

137. Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

138. Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consortium

139. Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC)

140. The increasing incidence of immigration and information-seeking behaviour of medical doctors in north-western Greece

141. Age-Dependent Invasion of Pseudorabies Virus into Porcine Central Nervous System via Maxillary Nerve

142. Comprehensive user requirements engineering methodology for secure and interoperable health data exchange

143. Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab

144. The Organisational Justice as a Human Resources Management Practice and its Impact on Employee Engagement: The case of the Prefecture of Attica (Greece)

145. Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia

146. KING OF THE HÜGEL.

149. MAIN-CAV: Phase III randomized trial of maintenance cabozantinib (CABO) and avelumab (Av) vs Av after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).

150. Comprehensive genomic profiling (CGP) of squamous cell carcinoma of unknown primary (SCCUP) presenting with inguinal, pelvic, and retroperitoneal (I/P/RP) metastases.

Catalog

Books, media, physical & digital resources